PD | Healthy Subjects N = 10 | P value* | ||||
---|---|---|---|---|---|---|
Early Patients N = 10 | Progressing Patients N = 11 | Total N = 21 | ||||
Age(years) | Range(Median ± SD) | 37 - 63(52.8 ± 8.18) | 49 - 78(62 ± 11.09) | 37 - 78(57.61 ± 10.67) | 23 - 71(55 ± 15.59) | p1 = 0.11 p2 = 0.38 p3 = 0.88 |
Gender(male or female) | Males/Females | 2/8 | 9/2 | 11/10 | 7/3 | p1 = 0.017 p2 = 0.07 p3 = 0.59 |
Duration of disease | Range(Median ± SD) | 1 - 7(4.6 ± 1.56) | 5 - 12(7.55 ± 2.25) | 1 - 12(6.17 ± 2.42) | - | p1 = 0.003 p2 < 0.05 p3 < 0.05 |
Hoehn-Yahr stage | Range(Median) | I-II(1.8) | III-IV(3.27) | I-IV(2.57) | - | p1 < 0.05 p2 < 0.05 p3 < 0.05 |
UPDRS Part III | Range(Median ± SD) | 9 - 43(29 ± 12.28) | 29 - 62(45.1 ± 10.89) | 9 - 62(37.86 ± 14.21) | - | p1 = 0.05 p2 < 0.05 p3 < 0.05 |
Side at onset | Right/Left | 5/5 | 7/4 | 12/9 | - | p1 = 0.85 p2 < 0.05 p3 < 0.05 |
Motor fluctuation# end of dose deterioration on-off phenomenon | Appearance(Yes or No) | Yes No | Yes Yes | - - | - - | - - |
NMSS | Range(Median ± SD) | 2 - 104(39.6 ± 29.90) | 9 - 147(51.18 ± 36.48) | 2 - 147(45.67 ± 33.21) | - | p1 = 0.29 p2 < 0.05 p3 < 0.05 |
MMSE MoCA | Range(Median ± SD) | 19 - 29(26 ± 3.21) 11 - 28(23.38 ± 5.32) | 17 - 30(24 ± 4.61) 8 - 29(20.5 ± 7.65) | 17 - 30(24.94 ± 4.02) 8 - 29(21.94 ± 6.54) | 27 - 30(28.6 ± 1.37) 26 - 29(27.6 ± 1.35) | p1 = 0.44 p2 = 0.02 p3 = 0.007 p1 = 0.67 p2 = 0.01 p3 = 0.003 |
HAMD HAMA | Range(Median ± SD) | 3 - 18(9.13 ± 6.49) 3 - 23(11.63 ± 6.49) | 3 - 20(9.44 ± 4.88) 4 - 25(11.22 ± 6.53) | 3 - 20(9.29 ± 5.51) 3 - 25(11.41 ± 6.97) | 1 - 7(4.8 ± 2.25) 1 - 12(7.6 ± 3.75) | p1 = 0.63 p2 = 0.28 p3 = 0.03 p1 = 0.92 p2 = 0.48 p3 = 0.27 |